This inventor holds 17 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Enveric Biosciences Canada Inc., Uti Limited Partnership, Other. Active years: 2018-2026.
Company Filing History:
12 out of 25 
3 out of 139 
2 out of 834,453 Years Active: 2018-2026
Title: **Chang-Chun Ling: Innovator in Psilocybin Derivatives in Calgary**
Introduction
Chang-Chun Ling is an accomplished inventor based in Calgary, Canada, known for his significant contributions to the field of pharmaceuticals. With a total of 13 patents to his name, Ling has focused on innovative compounds that could transform the landscape of both recreational and medicinal drug formulations.
Latest Patents
One of Chang-Chun Ling's latest patents, titled "Hydroxylated psilocybin derivatives and methods of using," introduces novel hydroxylated psilocybin derivative compounds. These compounds are versatile, allowing for synthetic or biosynthetic production, and may have various applications in pharmaceuticals and recreational products. Another cutting-edge patent is for "Multi-substituent psilocybin derivatives and methods of using." This patent discloses unique multi-substituent psilocybin derivative compounds which can be created by reacting a reactant psilocybin derivative with a suitable substituent-containing compound. Both patents promise to expand the possibilities in the psilocybin market.
Career Highlights
Throughout his career, Chang-Chun Ling has been associated with leading companies in the innovation sector, such as Enveric Biosciences Canada Inc. and Uti Limited Partnership. His work in these companies has been pivotal in advancing research and development in new medicinal compounds.
Collaborations
Chang-Chun Ling has collaborated with notable professionals in the industry, including Jillian M Hagel and Ping Zhang. These partnerships have likely enhanced the innovative aspects of his projects and have contributed to his success as a leading inventor.
Conclusion
With a solid foundation in pharmaceutical innovations and a focus on psilocybin derivatives, Chang-Chun Ling continues to make waves in the field of drug formulation. His inventive work not only exemplifies his dedication as an inventor but also promises to create impactful changes in medicinal and recreational markets. The future looks bright for this visionary innovator based in Calgary.